Cameco Tops Q1 Estimates as Higher Uranium Sales Lift Profit

Overview

• Cameco reported Tuesday it earned adjusted EPS of $0.34 versus the $0.29 consensus, with attributable net earnings of $131 million, or $0.30 per diluted share.
• Revenue totaled $845 million on a reported basis versus $789 million a year ago, while a Zacks-adjusted view showed $616.01 million that exceeded its estimate.
• Results were driven by higher uranium sales volumes and an average realized uranium price of $66.21 per pound, up from $62.55 a year earlier.
• Adjusted EBITDA reached C$509 million, rising from C$353 million in Q1 2025, and the company has now beaten EPS expectations in three of the last four quarters.
• CCJ shares are up 29.3% so far in 2026, and analysts still peg Q2 EPS near $0.37 and full‑year 2026 at $1.20 per share pending any revisions after the call.